Genetics have increased disease control and reduction likelihoods, and this is just the beginning. The lines have been pushed through newborn screening. More than ever, genetic testing has reached new heights.Read More
CBI Scene Blog
The FDA has a commitment to getting products to treat orphan diseases on the market as quickly as possible. Some of the people who have these diseases have no o
ther options for treatment, and a new drug could offer them their only hope of survival.
McKesson Patient Relationship Solutions (MPRS) is pleased to have been named a finalist in the 9th Annual Strategic Patient Adherence Awards, dedicated to recognizing excellence and advances in patient adherence. In advance of the Patient Adherence and Access Summit (PAAS), we wanted to preview the “Coupon Integration and Tracking within e-Prescribing Workflow” program, which was designed to provide brands with co-pay offset programs delivered through physicians’ e-Prescribing/EHR systems to patients at the point of prescribing.